MedComm - Oncology
Country
China
Asiatic Region
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
└
Oncology
Q1
└
Cancer Research
Q2
Publisher
SJR 2025
1.502
Q1
SJR Score
H-Index
14
Citations / Doc (2yr)
5.96
Total Docs. (latest)
41
Total Citations (3yr)
477
Publication type
Journals
ISSN
27696448
Coverage
2022-2026
Journal Rank
#2,442
Subject Categories
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Oncology
Q1
Cancer Research
Q2
Cell Biology
Q2
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 41 |
| Total Docs. (3 years) | 86 |
| Total Refs. | 6,035 |
| Total Citations (3 years) | 477 |
| Citable Docs. (3 years) | 81 |
| Citations / Doc. (2 years) | 5.96 |
| Ref. / Doc. | 147.20 |
| % Female | 43.2% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of MedComm - Oncology?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, MedComm - Oncology has an SJR of 1.502 and is ranked Q1.
What is the SJR and quartile of MedComm - Oncology?
MedComm - Oncology has an SJR (SCImago Journal Rank) of 1.502 and its best quartile is Q1.
What is the H-index of MedComm - Oncology?
The H-index of MedComm - Oncology is 14, meaning 14 of its articles have each been cited at least 14 times.
Is MedComm - Oncology indexed in Scopus?
Yes. MedComm - Oncology is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.